IQVIA Stock Jumps As Wall Street Targets Keep Climbing

IQVIA Holdings Inc. (IQV) stock has surged by 13.03% following strong earnings and positive guidance, prompting numerous Wall Street analysts to raise their price targets. Major banks like Deutsche Bank, HSBC, Mizuho, and Baird have all issued "Buy" or "Outperform" ratings with targets ranging from $225 to $252, well above its recent trading prices. The company's fundamental strength, including solid revenue, gross margins, and cash flow, along with its strategic role in clinical trial policy, underpins the growing bullish sentiment among traders despite a leveraged balance sheet.